BioCentury
ARTICLE | Distillery Therapeutics

CD34-positive melanocyte stem cells for demyelination diseases

May 28, 2019 5:49 PM UTC

INDICATION: Neurology...

BCIQ Company Profiles

University of Maryland

BCIQ Target Profiles

CD34